Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sohn, Seo Young | - |
dc.contributor.author | Jang, Hye Won | - |
dc.contributor.author | Cho, Yoon Young | - |
dc.contributor.author | Kim, Sun Wook | - |
dc.contributor.author | Chung, Jae Hoon | - |
dc.date.accessioned | 2022-07-15T19:39:32Z | - |
dc.date.available | 2022-07-15T19:39:32Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2015-12 | - |
dc.identifier.issn | 2093-596X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/155574 | - |
dc.description.abstract | Background: Previous studies have suggested that recombinant human thyroid stimulating hormone (rhTSH) stimulation is an acceptable alternative to thyroid hormone withdrawal (THW) when radioiodine remnant ablation is planned for thyroid cancer treatment, based on superior short-term quality of life with non-inferior remnant ablation efficacy. This study evaluated the cost-effectiveness of radioiodine remnant ablation using rhTSH, compared with the traditional preparation method which renders patients hypothyroid by THW, in Korean perspective. Methods: This economic evaluation considered the costs and benefits to the Korean public healthcare system. Clinical experts were surveyed regarding the current practice of radioiodine ablation in Korea and their responses helped inform assumptions used in a cost effectiveness model. Markov modelling with 17 weekly cycles was used to assess the incremental costs per quality-adjusted life year (QALY) associated with rhTSH. Clinical inputs were based on a multi-center, randomized controlled trial comparing remnant ablation success after rhTSH preparation with THW. The additional costs associated with rhTSH were considered relative to the clinical benefits and cost offsets. Results: The additional benefits of rhTSH (0.036 QALY) are achieved with an additional cost of Korean won ₩961,105, equating to cost per QALY of ₩26,697,361. Sensitivity analyses had only a modest impact upon cost-effectiveness, with one-way sensitivity results of approximately ₩33,000,000/QALY. Conclusion: The use of rhTSH is a cost-effective alternative to endogenous hypothyroid stimulation prior to radioiodine ablation for patients who have undergone thyroidectomy in Korea. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한내분비학회 | - |
dc.title | Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sohn, Seo Young | - |
dc.identifier.doi | 10.3803/EnM.2015.30.4.531 | - |
dc.identifier.scopusid | 2-s2.0-84955076981 | - |
dc.identifier.bibliographicCitation | Endocrinology and Metabolism, v.30, no.4, pp.531 - 542 | - |
dc.relation.isPartOf | Endocrinology and Metabolism | - |
dc.citation.title | Endocrinology and Metabolism | - |
dc.citation.volume | 30 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 531 | - |
dc.citation.endPage | 542 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.identifier.kciid | ART002062136 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Ablation | - |
dc.subject.keywordAuthor | Cost-effectiveness | - |
dc.subject.keywordAuthor | Hypothyroid | - |
dc.subject.keywordAuthor | Radioiodine | - |
dc.subject.keywordAuthor | Thyroid neoplasms | - |
dc.subject.keywordAuthor | Thyrotropin alfa | - |
dc.identifier.url | https://www.e-enm.org/journal/view.php?doi=10.3803/EnM.2015.30.4.531 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.